584 related items for PubMed ID: 8339809
1. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL.
Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
[Abstract] [Full Text] [Related]
2. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
[Abstract] [Full Text] [Related]
3. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C.
Thorax; 1993 Aug; 48(8):817-23. PubMed ID: 8211872
[Abstract] [Full Text] [Related]
4. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.
Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Uffelen R, Kesten S, Jones AL.
Respir Med; 1993 Nov; 87(8):609-20. PubMed ID: 8290745
[Abstract] [Full Text] [Related]
5. A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma.
Leblanc P, Mink S, Keistinen T, Saarelainen PA, Ringdal N, Payne SL.
Allergy; 1994 May; 49(5):380-5. PubMed ID: 8092438
[Abstract] [Full Text] [Related]
6. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
7. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A, Hall I, Spelman R.
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[Abstract] [Full Text] [Related]
8. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
Dahl R, Lundback B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, Barnacle H.
Chest; 1993 Nov; 104(5):1352-8. PubMed ID: 8222787
[Abstract] [Full Text] [Related]
9. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
Ayres JG, Bateman ED, Lundbäck B, Harris TA.
Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
[Abstract] [Full Text] [Related]
10. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
11. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A.
Eur Respir J; 1994 Dec; 7(12):2179-84. PubMed ID: 7713201
[Abstract] [Full Text] [Related]
12. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, van Herwaarden CL.
Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
[Abstract] [Full Text] [Related]
13. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H, Orozco S, Allen A.
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[Abstract] [Full Text] [Related]
14. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
Respir Med; 1996 Nov; 90(10):609-17. PubMed ID: 8959118
[Abstract] [Full Text] [Related]
15. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
Stoloff SW, Srebro SH, Edwards LD, Johnson MC, Rickard KA.
MedGenMed; 2001 Jun 08; 3(3):2. PubMed ID: 11549975
[Abstract] [Full Text] [Related]
16. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar 08; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
17. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
Eur Ann Allergy Clin Immunol; 2003 Nov 08; 35(9):356-62. PubMed ID: 14716965
[Abstract] [Full Text] [Related]
18. A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma.
Raphael GD, Lanier RQ, Baker J, Edwards L, Rickard K, Lincourt WR.
J Allergy Clin Immunol; 1999 May 08; 103(5 Pt 1):796-803. PubMed ID: 10329812
[Abstract] [Full Text] [Related]
19. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar 08; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
20. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK, Bates CE, Currie GP, Cowan LM, McFarlane LC, Lipworth BJ.
Ann Allergy Asthma Immunol; 2004 Sep 08; 93(3):253-8. PubMed ID: 15478385
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
